| SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer (NCT00005822) | Case Comprehensive Cancer Center | 2000-04-01 |
| Effects of Topical SLPI on Skin Wounds (NCT00005569) | National Institute of Dental and Craniofacial Research (NIDCR) | 2000-04-01 |
| Phase I Study of Amifostine in Patients With Bone Marrow Failure Related to Fanconi's Anemia (NCT00006127) | Dana-Farber Cancer Institute | 2000-04-01 |
| Allogeneic Epstein Barr Virus-Specific Cytotoxic T-Lymphocytes in Treating Patients With Progressive, Relapsed, or Refractory Hodgkin's Lymphoma (NCT00006100) | Milton S. Hershey Medical Center | 2000-04-01 |
| Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal Cancer (NCT00209625) | Hokkaido Gastrointestinal Cancer Study Group | 2000-04-01 |
| Tolerability and Pharmacokinetics of BIIB 722 CL Drinking Solution and of BIIB 722 CL Filmcoated Tablet in Healthy Subjects (NCT02227030) | Boehringer Ingelheim | 2000-04-01 |
| PS-341 in Treating Patients With Hematologic Cancer (NCT00006098) | Memorial Sloan Kettering Cancer Center | 2000-04-01 |
| Bcl-2 Antisense Oligodeoxynucleotide G3139 and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer (NCT00005032) | University of Chicago | 2000-04-01 |
| Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer (NCT00007826) | Onyvax | 2000-04-01 |
| Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum (NCT00005860) | Memorial Sloan Kettering Cancer Center | 2000-04-01 |
| Study to Evaluate the Effect of Multiple Doses of BIIL 284 BS on the Pharmacokinetics of Prednisone in Healthy Male Subjects (NCT02268149) | Boehringer Ingelheim | 2000-04-01 |
| Oxaliplatin in Treating Children With Advanced Solid Tumors (NCT00005844) | St. Jude Children's Research Hospital | 2000-04-01 |
| Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory Leukemia (NCT00006040) | Memorial Sloan Kettering Cancer Center | 2000-04-01 |
| O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma (NCT00004892) | National Cancer Institute (NCI) | 2000-04-01 |
| Safety, Tolerability, Pharmacokinetics (Including Food Interaction), and Pharmacodynamics of BIA 3-202 (NCT02763787) | Bial - Portela C S.A. | 2000-04-01 |
| LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer (NCT00005858) | University of Maryland, Baltimore | 2000-04-01 |
| BMS-214662 in Treating Patients With Solid Tumors (NCT00005973) | National Cancer Institute (NCI) | 2000-04-01 |
| BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia (NCT00006213) | National Cancer Institute (NCI) | 2000-04-01 |
| Evaluation of the Compress Distal Femoral Replacement System (NCT00591812) | Memorial Sloan Kettering Cancer Center | 2000-04-01 |
| Comparison of Pharmacokinetics of Dipyridamole in Asasantin Extended Release (ER) and in a Combination of Persantin Immediate Release Tablets and ASA Tablets in Healthy Subjects (NCT02273505) | Boehringer Ingelheim | 2000-04-01 |
| hOKT3γ1 (Ala-Ala) Combined With Sirolimus and Delayed Tacrolimus in Type 1 Diabetic Islet Allograft Recipients (NCT00285194) | University of Minnesota | 2000-04-01 |
| Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the Pancreas That Cannot Be Removed by Surgery (NCT00003798) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2000-04-01 |
| Combination Chemotherapy in Treating Patients With Advanced Solid Tumors (NCT00005819) | Case Comprehensive Cancer Center | 2000-04-01 |
| A Trial of ABI-007 in Patients With Advanced Non-Hematologic Malignancies (NCT00046423) | Celgene Corporation | 2000-04-01 |
| The Safety and Effectiveness of (+)-Calanolide A in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs (NCT00005120) | Sarawak MediChem Pharmaceuticals | 2000-04-01 |
| Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer (NCT00005046) | Gynecologic Oncology Group | 2000-04-01 |
| Vaccine Therapy in Treating Patients With Advanced Cancer (NCT00004881) | Jonsson Comprehensive Cancer Center | 2000-04-01 |
| Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer (NCT00004879) | Jonsson Comprehensive Cancer Center | 2000-04-01 |
| Pharmacokinetics of Simvastatin and Its Metabolite Simvastatin Acid With and Without Concomitant Administration of Telmisartan in Healthy Subjects (NCT02187536) | Boehringer Ingelheim | 2000-04-01 |
| Radiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT00058292) | Northwestern University | 2000-04-01 |
| SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy (NCT00004868) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2000-03-24 |
| Diagnosis of Pheochromocytoma (NCT00004847) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2000-03-22 |
| Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors (NCT00006036) | NCIC Clinical Trials Group | 2000-03-22 |
| Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive Chemotherapy (NCT00004853) | National Cancer Institute (NCI) | 2000-03-03 |
| Endostatin in Treating Patients With Advanced Refractory Solid Tumors (NCT00004872) | University of Wisconsin, Madison | 2000-03-01 |
| SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer (NCT00005818) | National Cancer Institute (NCI) | 2000-03-01 |
| A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors (NCT00251797) | University of New Mexico | 2000-03-01 |
| Docetaxel and Oxaliplatin in Treating Patients With Metastatic or Recurrent Solid Tumor (NCT00004243) | City of Hope Medical Center | 2000-03-01 |
| Morphine Gel for Bedsores (NCT00007254) | University of Kansas | 2000-03-01 |
| Safety, Pharmacokinetics and Pharmacodynamics of BIRB 796 BS Tablets Administered to Healthy Human Subjects (NCT02211157) | Boehringer Ingelheim | 2000-03-01 |
| Evaluation of Cyberknife Precision Radiation Delivery System for Unresectable Malignant Lung Cancer (NCT00238602) | Stanford University | 2000-03-01 |
| Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer (NCT00017537) | University of Alabama at Birmingham | 2000-03-01 |
| Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Patients With Hepatic Impairment in Comparison to Healthy Volunteers (NCT02265627) | Boehringer Ingelheim | 2000-03-01 |
| Intensity-Modulated Radiation Therapy in Treating Patients With Prostate Cancer (NCT00946543) | Royal Marsden NHS Foundation Trust | 2000-03-01 |
| Phase I Pilot Study of CD34 Enriched, Fanconi's Anemia Complementation Group C Gene Transduced Autologous Peripheral Blood Stem Cell Transplantation in Patients With Fanconi's Anemia (NCT00005896) | University of Minnesota | 2000-03-01 |
| Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma (NCT00004244) | National Cancer Institute (NCI) | 2000-03-01 |
| Safety and Efficacy of SmithKline Beecham (GlaxoSmithKline [GSK]) Biologicals' Candidate Adjuvanted Vaccines (287615) (NCT00508833) | GlaxoSmithKline | 2000-03-01 |
| Continuous Infusion Gemcitabine in Treating Patients With Advanced Metastatic Cancer (NCT00020644) | Advocate Lutheran General Hospital | 2000-03-01 |
| The Use of Breathing Synchronized CT and PET Scans in Radiation Therapy Treatment Planning (NCT00588328) | Memorial Sloan Kettering Cancer Center | 2000-03-01 |
| Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment (NCT00005639) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2000-03-01 |
| Treatment of Patients With Cancer With Genetically Modified Salmonella Typhimurium Bacteria (NCT00004988) | National Cancer Institute (NCI) | 2000-03-01 |
| Pharmacological Study on Absorption of WE 941 OD Tablets in Japanese Healthy Male Volunteers (NCT02218671) | Boehringer Ingelheim | 2000-03-01 |
| Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma (NCT00005057) | National Human Genome Research Institute (NHGRI) | 2000-03-01 |
| Study of Noscapine for Patients With Low Grade Non Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Refractory to Chemotherapy (NCT00183950) | University of Southern California | 2000-03-01 |
| Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy (NCT00005942) | National Cancer Institute (NCI) | 2000-03-01 |
| A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders (NCT00005783) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2000-03-01 |
| To Demonstrate the Relative Bioequivalence of Lisinopril 1 x 40 mg Tablets Under Fasting Conditions (NCT00883064) | Sandoz | 2000-03-01 |
| Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma (NCT00020111) | National Cancer Institute (NCI) | 2000-03-01 |
| Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors (NCT00014456) | Dartmouth-Hitchcock Medical Center | 2000-03-01 |
| Tirapazamine, Carboplatin, and Paclitaxel in Treating Patients With Advanced Malignant Solid Tumors (NCT00005078) | City of Hope Medical Center | 2000-03-01 |
| Interleukin-12 Plus Interleukin-2 in Treating Patients With Advanced Solid Tumors (NCT00005604) | National Cancer Institute (NCI) | 2000-03-01 |
| Monoclonal Antibody Therapy in Treating Patients With Recurrent Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma (NCT00004858) | Parker Hughes Cancer Center | 2000-03-01 |
| Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia (NCT00630253) | Masonic Cancer Center, University of Minnesota | 2000-02-17 |
| FIM-NL - First-in-Man Study (Netherlands Part) With Sirolimus Coated Modified BX Velocity Stent (NCT00233818) | Cordis US Corp. | 2000-02-01 |
| Combination Chemotherapy in Treating Patients With Advanced Solid Tumors (NCT00006372) | Case Comprehensive Cancer Center | 2000-02-01 |
| Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer (NCT00005026) | Gynecologic Oncology Group | 2000-02-01 |
| Photodynamic Therapy With Lutetium Texaphyrin in Treating Patients With Locally Recurrent Prostate Cancer (NCT00005067) | National Cancer Institute (NCI) | 2000-02-01 |
| Study to Determine Tolerability of Single Increasing Dose of BIBN 4096 BS in Healthy Male and Female Volunteers (NCT02194348) | Boehringer Ingelheim | 2000-02-01 |
| Phase I/II Study of Total Body Irradiation, Cyclophosphamide, and Fludarabine Followed by Alternate Donor Hematopoietic Cell Transplantation in Patients With Fanconi's Anemia (NCT00005898) | University of Minnesota | 2000-02-01 |
| Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer (NCT00005851) | Fred Hutchinson Cancer Center | 2000-02-01 |
| Vaccine Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer (NCT00006041) | Memorial Sloan Kettering Cancer Center | 2000-02-01 |
| Effects of Miconazole on Blood Flow (NCT00004575) | National Heart, Lung, and Blood Institute (NHLBI) | 2000-02-01 |
| Gemcitabine Plus Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Solid Tumor (NCT00004159) | University of Alabama at Birmingham | 2000-02-01 |
| Cancer Immune Therapy for the Treatment of Refractory Solid Tumours of Childhood (NCT02533895) | Activartis Biotech | 2000-02-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ESR 1150 CL in Healthy Subjects (NCT02209688) | Boehringer Ingelheim | 2000-02-01 |
| Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors (NCT00005796) | Indiana University | 2000-02-01 |
| Perifosine in Treating Patients With Advanced Solid Tumors (NCT00005794) | University of Wisconsin, Madison | 2000-02-01 |
| PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome (NCT00005064) | National Cancer Institute (NCI) | 2000-02-01 |
| Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer (NCT00005816) | Duke University | 2000-02-01 |
| Gene Therapy in Treating Patients With Metastatic Melanoma (NCT00005943) | University of Colorado, Denver | 2000-02-01 |
| Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer (NCT00008034) | European Organisation for Research and Treatment of Cancer - EORTC | 2000-02-01 |
| Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer (NCT00041652) | Gilead Sciences | 2000-02-01 |
| Tolerability of Asasantin in Healthy Female and Male Subjects (NCT02269228) | Boehringer Ingelheim | 2000-02-01 |
| Hypertension: Prediction of Biofeedback Success (NCT00026065) | National Center for Complementary and Integrative Health (NCCIH) | 2000-02-01 |
| Testosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone Therapy (NCT00006044) | Memorial Sloan Kettering Cancer Center | 2000-02-01 |
| Effect of Single Oral Dose BIRB 796 BS on Endotoxin-induced Inflammatory Responses in Healthy Human Subjects (NCT02211170) | Boehringer Ingelheim | 2000-02-01 |
| Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed (NCT00004160) | University of Alabama at Birmingham | 2000-02-01 |
| Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy (NCT00005988) | Dana-Farber Cancer Institute | 2000-02-01 |
| Metoprolol in Acute Myocardial Infarction. A PK/PD Study (NCT01523054) | AstraZeneca | 2000-02-01 |
| Docetaxel and Carboplatin Followed by Oral Capecitabine, Docetaxel and Radiation for Esophageal Cancer (NCT00153881) | Dartmouth-Hitchcock Medical Center | 2000-02-01 |
| Pharmacokinetics of Biphasic Insulin Aspart 50 and 70 in Japanese Healthy Volunteers (NCT01620333) | Novo Nordisk A/S | 2000-02-01 |
| Clinical Study on 5-aminolevulinic Acid Hydrochloride (5-ALA) for Fluorescence-guided Resection of Malignant Gliomas (NCT02755142) | medac GmbH | 2000-02-01 |
| Effect of Different Food Compositions on Bioavailability of BIIL 284 BS in Healthy Male Volunteers (NCT02273427) | Boehringer Ingelheim | 2000-02-01 |
| Inflammation and the Host Response to Injury (In Healthy Volunteers) (NCT00820989) | Rutgers, The State University of New Jersey | 2000-02-01 |
| Preventive Home Visits for Healthy Pensioners- a Randomized Controlled Trial (NCT00250003) | Umeå University | 2000-02-01 |
| Oxaliplatin in Treating Patients With Advanced Cancer Plus Liver Dysfunction (NCT00005077) | City of Hope Medical Center | 2000-02-01 |
| Gentamicin Treatment of Muscular Dystrophy (NCT00005574) | National Institute of Neurological Disorders and Stroke (NINDS) | 2000-02-01 |
| Safety Study of 90Y-hMN14 to Treat Colorectal Cancer (NCT00040599) | Gilead Sciences | 2000-01-01 |
| Single Increasing Doses of BIII 890 CL in Healthy Young Male Volunteers and in Healthy Elderly Male and Female Volunteers (NCT02269215) | Boehringer Ingelheim | 2000-01-01 |
| Safety, Pk and Anti-inflammatory Effects of CC10 Protein in Premature Infants With Respiratory Distress Syndrome (RDS) (NCT01473264) | Clarassance, Inc. | 2000-01-01 |